New Insights into the Management of CKD in T2D: The Role of MRA Therapies - a podcast by ReachMD

CME credits: 0.25

Valid until: 07-01-2023

Claim your CME credit at https://reachmd.com/programs/cme/new-insights-into-the-management-of-ckd-in-t2d-the-role-of-mra-therapies/13097/

Achieving optimal outcomes in the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) remains a challenge, and treating physicians need to embrace multidisciplinary components when managing progression to CKD.

In this discussion, Drs. Gerasimos Filippatos, Peter Rossing, and Matthew Weir review the unmet needs of patients with CKD and T2D. They also explore the role of mineralocorticoid receptor antagonists (MRAs) in the treatment spectrum and review recent findings from clinical trials. Tune in to ensure you’re doing all you can for each of your patients.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD